
Intrauterine Devices Market by Type (Hormonal: Progestogen-releasing IUD, Nonhormonal: Copper-containing IUD), Age Group (15-24 Years, 25-34 Years, 35-44 Years), End User - Global Forecast 2024-2030
Description
Intrauterine Devices Market by Type (Hormonal: Progestogen-releasing IUD, Nonhormonal: Copper-containing IUD), Age Group (15-24 Years, 25-34 Years, 35-44 Years), End User - Global Forecast 2024-2030
The Intrauterine Devices Market size was estimated at USD 3.13 billion in 2023 and expected to reach USD 3.24 billion in 2024, at a CAGR 4.59% to reach USD 4.29 billion by 2030.
Global Intrauterine Devices Market
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Intrauterine Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Intrauterine Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Intrauterine Devices Market, highlighting leading vendors and their innovative profiles. These include Actavis Generics by Teva Pharmaceutical Industries Ltd., Agile Therapeutics, Inc., Allergan Plc by Abbvie Inc, Ava AG, Bayer AG, Cardinal Health, Inc., Contrel Europe NV, CooperSurgical Inc., Egemen International, ERENLER MEDİKAL SAN. TİC. LTD. ŞTİ., Eurogine S.L., Fuji Latex Co., Ltd., HLL Lifecare Limited, HRA Pharma, SAS, Melbea AG, Merck & Co., Inc., Meril Life Sciences Pvt. Ltd., Mona Lisa N.V., Mylan NV by Viatris Inc., Novartis AG, Ocon Medical Ltd, Pregna International Limited, Prosan International BV, Searchlight Pharma Inc., and SMB Corporation of India.
Market Segmentation & Coverage
This research report categorizes the Intrauterine Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:
Type
Hormonal: Progestogen-releasing IUD
Nonhormonal: Copper-containing IUD
Age Group
15-24 Years
25-34 Years
35-44 Years
Above 44 Years
End User
Clinics
Community Health Care Centres
Hospitals
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Intrauterine Devices Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Intrauterine Devices Market?
3. What are the technology trends and regulatory frameworks in the Intrauterine Devices Market?
4. What is the market share of the leading vendors in the Intrauterine Devices Market?
5. Which modes and strategic moves are suitable for entering the Intrauterine Devices Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
185 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Intrauterine Devices Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rising adoption to avoid unintended pregnancies
- 5.1.1.2. Government and NGO initiatives to promote IUD
- 5.1.2. Restraints
- 5.1.2.1. Concerns related to lost strings and risk of infection due to IUD usage
- 5.1.3. Opportunities
- 5.1.3.1. Focus on the design of next-generation IUD (intrauterine device)
- 5.1.3.2. Emergence of smart intrauterine contraceptive device
- 5.1.4. Challenges
- 5.1.4.1. Limited awareness and adoption among population
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Intrauterine Devices Market, by Type
- 6.1. Introduction
- 6.2. Hormonal: Progestogen-releasing IUD
- 6.3. Nonhormonal: Copper-containing IUD
- 7. Intrauterine Devices Market, by Age Group
- 7.1. Introduction
- 7.2. 15-24 Years
- 7.3. 25-34 Years
- 7.4. 35-44 Years
- 7.5. Above 44 Years
- 8. Intrauterine Devices Market, by End User
- 8.1. Introduction
- 8.2. Clinics
- 8.3. Community Health Care Centres
- 8.4. Hospitals
- 9. Americas Intrauterine Devices Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific Intrauterine Devices Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.
- 10. South Korea
- 10.
- 11. Taiwan
- 10.
- 12. Thailand
- 10.
- 13. Vietnam
- 11. Europe, Middle East & Africa Intrauterine Devices Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.
- 10. Nigeria
- 11.
- 11. Norway
- 11.
- 12. Poland
- 11.
- 13. Qatar
- 11.
- 14. Russia
- 11.
- 15. Saudi Arabia
- 11.
- 16. South Africa
- 11.
- 17. Spain
- 11.
- 18. Sweden
- 11.
- 19. Switzerland
- 11.
- 20. Turkey
- 11.
- 21. United Arab Emirates
- 11.
- 22. United Kingdom
- 12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. Actavis Generics by Teva Pharmaceutical Industries Ltd.
- 13.1.2. Agile Therapeutics, Inc.
- 13.1.3. Allergan Plc by Abbvie Inc
- 13.1.4. Ava AG
- 13.1.5. Bayer AG
- 13.1.6. Cardinal Health, Inc.
- 13.1.7. Contrel Europe NV
- 13.1.8. CooperSurgical Inc.
- 13.1.9. Egemen International
- 13.1.
- 10. ERENLER MEDİKAL SAN. TİC. LTD. ŞTİ.
- 13.1.
- 11. Eurogine S.L.
- 13.1.
- 12. Fuji Latex Co., Ltd.
- 13.1.
- 13. HLL Lifecare Limited
- 13.1.
- 14. HRA Pharma, SAS
- 13.1.
- 15. Melbea AG
- 13.1.
- 16. Merck & Co., Inc.
- 13.1.
- 17. Meril Life Sciences Pvt. Ltd.
- 13.1.
- 18. Mona Lisa N.V.
- 13.1.
- 19. Mylan NV by Viatris Inc.
- 13.1.
- 20. Novartis AG
- 13.1.
- 21. Ocon Medical Ltd
- 13.1.
- 22. Pregna International Limited
- 13.1.
- 23. Prosan International BV
- 13.1.
- 24. Searchlight Pharma Inc.
- 13.1.
- 25. SMB Corporation of India
- 13.2. Key Product Portfolio
- 14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
- FIGURE 1. INTRAUTERINE DEVICES MARKET RESEARCH PROCESS
- FIGURE 2. INTRAUTERINE DEVICES MARKET SIZE, 2023 VS 2030
- FIGURE 3. INTRAUTERINE DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. INTRAUTERINE DEVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. INTRAUTERINE DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. INTRAUTERINE DEVICES MARKET DYNAMICS
- FIGURE 7. INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
- FIGURE 8. INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
- FIGURE 10. INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
- FIGURE 12. INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AMERICAS INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 14. AMERICAS INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. UNITED STATES INTRAUTERINE DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 16. UNITED STATES INTRAUTERINE DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. INTRAUTERINE DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 22. INTRAUTERINE DEVICES MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.